One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial.

IF 11.4 1区 医学 Q1 ALLERGY Journal of Allergy and Clinical Immunology Pub Date : 2024-09-02 DOI:10.1016/j.jaci.2024.08.023
Kara L Kliewer, J Pablo Abonia, Seema S Aceves, Dan Atkins, Peter A Bonis, Kelley E Capocelli, Mirna Chehade, Margaret H Collins, Evan S Dellon, Lin Fei, Glenn T Furuta, Sandeep K Gupta, Amir Kagalwalla, John Leung, Sabina Mir, Vincent A Mukkada, Robbie Pesek, Chen Rosenberg, Tetsuo Shoda, Jonathan M Spergel, Qin Sun, Joshua B Wechsler, Guang-Yu Yang, Marc E Rothenberg
{"title":"One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial.","authors":"Kara L Kliewer, J Pablo Abonia, Seema S Aceves, Dan Atkins, Peter A Bonis, Kelley E Capocelli, Mirna Chehade, Margaret H Collins, Evan S Dellon, Lin Fei, Glenn T Furuta, Sandeep K Gupta, Amir Kagalwalla, John Leung, Sabina Mir, Vincent A Mukkada, Robbie Pesek, Chen Rosenberg, Tetsuo Shoda, Jonathan M Spergel, Qin Sun, Joshua B Wechsler, Guang-Yu Yang, Marc E Rothenberg","doi":"10.1016/j.jaci.2024.08.023","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A 6-food elimination diet in pediatric eosinophilic esophagitis (EoE) is difficult to implement and may negatively affect quality of life (QoL). Less restrictive elimination diets may balance QoL and efficacy.</p><p><strong>Objective: </strong>We performed a multisite, randomized comparative efficacy trial of a 1-food (milk) elimination diet (1FED) versus 4-food (milk, egg, wheat, soy) elimination diet (4FED) in pediatric EoE.</p><p><strong>Methods: </strong>Patients aged 6 to 17 years with histologically active and symptomatic EoE were randomized 1:1 to 1FED or 4FED for 12 weeks. Primary end point was symptom improvement by Pediatric Eosinophilic Esophagitis Symptom Score (PEESS). Secondary end points were proportion experiencing histologic remission (<15 eosinophils per high-power field); change in histologic features (histology scoring system), endoscopic severity (endoscopic reference score), transcriptome (EoE diagnostic panel), and QoL scores; and predictors of remission.</p><p><strong>Results: </strong>Sixty-three patients were randomly assigned to 1FED (n = 38) and 4FED (n = 25). In 4FED versus 1FED, mean PEESS improved -25.0 versus -14.5 (P = .04), but remission rates (41% vs 44%; P = 1.00), histology scoring system (-0.25 vs -0.29; P = .77), endoscopic reference score (-1.10 vs -0.58; P = .47), and QoL scores were similar between groups. The EoE transcriptome normalized in those with histologic response to both diets. Baseline peak eosinophil count predicted remission (odds ratio, 0.975 [95% confidence interval, 0.953-0.999], P = .04; cutoff ≤42 eosinophils per high-power field). The 4FED withdrawal rate (32%) exceeded that of 1FED (11%) (P = .0496).</p><p><strong>Conclusions: </strong>Although 4FED moderately improved symptoms compared with 1FED, the histologic, endoscopic, QoL, and transcriptomic outcomes were similar in both groups. 1FED is a reasonable first-choice therapy for pediatric EoE, given its effects, tolerability, and relative simplicity.</p>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":null,"pages":null},"PeriodicalIF":11.4000,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaci.2024.08.023","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A 6-food elimination diet in pediatric eosinophilic esophagitis (EoE) is difficult to implement and may negatively affect quality of life (QoL). Less restrictive elimination diets may balance QoL and efficacy.

Objective: We performed a multisite, randomized comparative efficacy trial of a 1-food (milk) elimination diet (1FED) versus 4-food (milk, egg, wheat, soy) elimination diet (4FED) in pediatric EoE.

Methods: Patients aged 6 to 17 years with histologically active and symptomatic EoE were randomized 1:1 to 1FED or 4FED for 12 weeks. Primary end point was symptom improvement by Pediatric Eosinophilic Esophagitis Symptom Score (PEESS). Secondary end points were proportion experiencing histologic remission (<15 eosinophils per high-power field); change in histologic features (histology scoring system), endoscopic severity (endoscopic reference score), transcriptome (EoE diagnostic panel), and QoL scores; and predictors of remission.

Results: Sixty-three patients were randomly assigned to 1FED (n = 38) and 4FED (n = 25). In 4FED versus 1FED, mean PEESS improved -25.0 versus -14.5 (P = .04), but remission rates (41% vs 44%; P = 1.00), histology scoring system (-0.25 vs -0.29; P = .77), endoscopic reference score (-1.10 vs -0.58; P = .47), and QoL scores were similar between groups. The EoE transcriptome normalized in those with histologic response to both diets. Baseline peak eosinophil count predicted remission (odds ratio, 0.975 [95% confidence interval, 0.953-0.999], P = .04; cutoff ≤42 eosinophils per high-power field). The 4FED withdrawal rate (32%) exceeded that of 1FED (11%) (P = .0496).

Conclusions: Although 4FED moderately improved symptoms compared with 1FED, the histologic, endoscopic, QoL, and transcriptomic outcomes were similar in both groups. 1FED is a reasonable first-choice therapy for pediatric EoE, given its effects, tolerability, and relative simplicity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
治疗小儿嗜酸性粒细胞食管炎的 1 种食物与 4 种食物消除饮食法:多地点随机试验。
背景:小儿嗜酸性粒细胞食管炎(EoE)患者的 6 种食物排除饮食很难实施,而且可能对生活质量(QoL)产生负面影响。限制较少的排除性饮食可在生活质量和疗效之间取得平衡:我们在多个地点进行了一项随机疗效比较试验,对小儿 EoE 进行了 1 种食物(牛奶)排除饮食(1FED)与 4 种食物(牛奶、鸡蛋、小麦、大豆)排除饮食(4FED)的比较:年龄在 6 至 17 岁之间、组织学表现活跃且有症状的肠炎患者按 1:1 随机分配到 1FED 或 4FED 食物中,为期 12 周。主要终点是小儿咽喉炎症状评分(PEESSv2.0)显示的症状改善情况。次要终点是达到组织学缓解的比例(结果:63 名患者被随机分配到 1FED 或 4FED 治疗方案:63名患者被随机分配到1FED(38人)和4FED(25人)。4FED与1FED相比,平均PEESSv2.0改善了-25.0与-14.5(p=0.04),但缓解率(41%与44%;p=1.00)、HSS(-0.25与-0.29;p=0.77)、EREFS(-1.10与-0.58;p=0.47)和QoL评分在组间相似。两种饮食的组织学应答者的嗜酸性粒细胞转录组均恢复正常。嗜酸性粒细胞基线峰值计数可预测病情缓解(OR 0.975,95% CI 0.953-0.999,p=0.04;临界值≤42 eos/hpf)。4FED的停药率(32%)超过了1FED(11%)(P=0.0496):尽管与 1FED 相比,4FED 可适度改善症状,但两组的组织学、内镜、QoL 和转录组学结果相似。鉴于其效果、耐受性和相对简单性,1FED 是治疗小儿咽喉炎的合理首选疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
25.90
自引率
7.70%
发文量
1302
审稿时长
38 days
期刊介绍: The Journal of Allergy and Clinical Immunology is a prestigious publication that features groundbreaking research in the fields of Allergy, Asthma, and Immunology. This influential journal publishes high-impact research papers that explore various topics, including asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases. The articles not only report on clinical trials and mechanistic studies but also provide insights into novel therapies, underlying mechanisms, and important discoveries that contribute to our understanding of these diseases. By sharing this valuable information, the journal aims to enhance the diagnosis and management of patients in the future.
期刊最新文献
Association of CD19+-Targeted Chimeric Antigen Receptor (CAR) T-cell Therapy with Hypogammaglobulinemia, Infection and Mortality. Anti-IgE and Food Allergy. Baseline Epitope-Specific IgE Profiles are Predictive of Sustained Unresponsiveness or High Threshold One-Year Post OIT in the POISED Trial. Covid-19 mRNA vaccine allergy. Reply
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1